bibliographic entry 2492504 [be/2492504]
https://w3id.org/oc/corpus/be/2492504

is a
content
  • RidderstrÃ¥le, M, Andersen, KR, Zeller, C, Kim, G, Woerle, HJ, Broedl, UC. Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial, Lancet Diabetes Endocrinol, 2014, 2, 9, 691, 700, PMID: 24948511
references